Latest Clinical research Stories
- Evaluating and advancing investigational PEGPH20 in two cancer settings associated with low survival - SAN DIEGO, Jan. 12, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
ALBANY, N.Y., Jan.
-- First Observation of Dose Limiting Toxicity Signals VAL-083's Potential Advancement Toward Registration Directed Clinical Trials in Refractory Glioblastoma -- VANCOUVER, British Columbia
Rnrmarketresearch.com adds “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015” to its store.
NEW YORK, Jan. 9, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AMAG Pharmaceuticals, Inc. ("AMAG" or the "Company").
MISSISSAUGA, ON, Jan. 9, 2015 /PRNewswire/ - Cipher Pharmaceuticals Inc.
JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company has successfully completed the initial Phase 3 clinical trial (ETTAU-02) on its
ERT’s Solutions Utilized in over Half of FDA Approvals PHILADELPHIA (PRWEB) January 08, 2015 ERT, a leading global solution provider for high-quality
Increased Competition Lowers Drug Costs Washington D.C.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.